Sponsor Pipeline

Tr1X, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
6
Disease Areas
Active Trials by Phase
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06721962 Treatment of Moderate to Severe Refractory Crohn's Disease Crohns Disease Recruiting
NCT07477639 Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis Primary Progressive Multiple Sclerosis Recruiting
Phase 1
NCT06462365 Prevention of GvHD in Participants With Hematological Malignancies Undergoing… Hematologic Malignancy Recruiting
Disease Areas
Leukemia (1) Acute Myeloid Leukemia (AML) (1) Acute Lymphoblastic Leukemia (ALL) (1) Myelodysplastic Syndromes (MDS) (1) Crohn's Disease (1) Multiple Sclerosis (1)
Get alerts when Tr1X, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free